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Abstract We investigated the effect of PGE2 and iloprost (a
prostacyclin analogue) on inducible nitric oxide synthase (iNOS)
protein expression and nuclear factor-UB (NF-UB) activation in
lipopolysaccharide (LPS)-stimulated J774 macrophages. Incu-
bation of J774 cells with LPS (10 Wg/ml) caused an increase of
iNOS protein expression which was prevented in a concentration-
dependent fashion by PGE2 (0.1, 1, 10 WM) and iloprost (0.01,
0.1, 1 WM). Electrophoretic mobility shift assay indicated that
both prostanoids blocked the activation of NF-UB, a transcrip-
tion factor necessary for NO synthase induction. PGE2 and
iloprost also blocked disappearance of IUB-K from cytosolic
fraction and nuclear translocation of NF-UB subunits p50 and
p65. These results show for the first time that PGE2 and iloprost
down-regulate iNOS protein expression by inhibiting NF-UB
activation and suggest a negative feed-back mechanism that may
be important for limiting excessive or prolonged NO production
in pathological events.
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1. Introduction
Prostaglandins (PGs) play an important role as mediators
of the in£ammatory response. Cyclooxygenase (COX), the
key enzyme for PGs generation from arachidonic acid, has
been found in two forms [1]. After stimulation with bacterial
lipopolysaccharide (LPS) or some cytokines, many cell types,
including endothelial cells and macrophages, express the in-
ducible isoform (COX-2) which is responsible for the produc-
tion of large amounts of proin£ammatory PGs at the in£am-
mation site [2,3]. Several lines of evidence suggest that PGs
may modulate macrophage activation process by blocking the
release of some cytotoxic/cytostatic molecules such as nitric
oxide (NO) [4,5]. NO, a short lived mediator, is synthesised by
a family of enzymes termed NO-synthase (NOS), which utilise
L-arginine as the substrate for the generation of NO and equal
amounts of citrulline [6]. Two types of NOS are recognised:
constitutive isoforms (endothelial NOS or eNOS and neuronal
NOS or nNOS) which are active for relative short time in
response to intracellular Ca2 £uctuations, and a Ca2-inde-
pendent inducible isoform for which mRNA translation and
protein synthesis are required [6,7]. Inducible NOS (iNOS) is
regulated by in£ammatory mediators, and the excessive pro-
duction of NO by iNOS has been implicated in the patho-
genesis of the in£ammatory response [8^11]. The transcription
factor NF-UB plays a critical role in the transcriptional regu-
lation of iNOS gene induced by LPS and cytokines [12]. NF-
UB is a ubiquitous transcription factor composed of a group
of nuclear proteins: c-Rel, p50/p105 (NF-UB1), p65 (Rel A),
p52/p100 (NF-UB2) and Rel B. NF-UB complexes are seques-
tered in the cytoplasm of most resting cells by inhibitory pro-
teins belonging to the IUB family. In response to various stim-
uli IUB-K is ¢rst phosphorylated and then rapidly degraded by
the proteasome, allowing NF-UB nuclear translocation and
gene activation [13,14]. We have previously shown that
PGE2 and iloprost (a prostacyclin analogue) inhibit NO gen-
eration in LPS-stimulated J774 macrophages [4]. Recently, it
has been reported that the prostaglandin-cyclic AMP system
can a¡ect the LPS-induced iNOS and COX-2 protein expres-
sion in J774 macrophages [15]. In the light of these ¢ndings,
since the activation of NF-UB has been shown to be an essen-
tial step in the induction of iNOS expression, we have inves-
tigated whether PGE2 and iloprost were able to down-regulate
the iNOS protein expression by inhibiting NF-UB activation
in LPS-treated J774 macrophages.
2. Materials and methods
2.1. Cell culture
The murine monocyte/macrophage cell line J774 was cultured at
37‡C in humidi¢ed 5% CO2/95% air in DMEM containing 10% foetal
bovine serum, 2 mM glutamine, 100 UI/ml penicillin and 100 Wg/ml
streptomycin. The cells were plated in 24-culture wells at a density of
2.5U105 cells/ml/well or 10-cm diameter culture dishes at a density of
1U107 cells/ml/dish and allowed to adhere for 2 h. Thereafter the
medium was replaced with fresh medium and cells were activated
with LPS (10 Wg/ml). PGE2 (1, 10, 100 WM) or iloprost (0.1, 1, 10
WM) were added to the cells 20 min before LPS challenge. In some
experiments PGE2 (10 WM) or iloprost (1 WM) were added 12 h after
LPS challenge. NO generation was measured as nitrite (NO32 , nmol/
106 cells) accumulated in the incubation media (6, 12, 24 h after LPS
challenge) using a spectrophotometric assay based on Griess reaction
[16] and cell viability (s 95%) was determined by using MTT assay
[17].
2.2. Preparation of cytosolic and nuclear extracts
Extracts of macrophages stimulated for 2 h with LPS (10 Wg/ml) in
the presence or absence of PGE2 (1, 10, 100 WM) or iloprost (0.1, 1, 10
WM) were prepared as described [18]. Brie£y, harvested cells (2U107)
were washed two times with ice-cold PBS and centrifuged at 180Ug
for 10 min at 4‡C. The cell pellet was resuspended in 100 Wl of ice-cold
hypotonic lysis bu¡er (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl,
0.5 mM phenylmethylsulfonyl£uoride, 1.5 Wg/ml soybean trypsin in-
hibitor, 7 Wg/ml pepstatin A, 5 Wg/ml leupeptin, 0.1 mM benzamidine,
0.5 mM DTT) and incubated on ice for 15 min. The cells were lysed
by rapid passage through a syringe needle for 5^6 times and the
cytoplasmic fraction was then obtained by centrifugation for 1 min
at 13 000Ug for 1 min. The nuclear pellet was resuspended in 60 Wl of
high salt extraction bu¡er (20 mM HEPES, pH 7.9, 420 mM NaCl,
1.5 mM MgCl2, 0.2 mM EDTA, 25% v/v glycerol, 0.5 mM phenyl-
methylsulfonyl£uoride, 1.5 Wg/ml soybean trypsin inhibitor, 7 Wg/ml
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pepstatin A, 5 Wg/ml leupeptin, 0.1 mM benzamidine, 0.5 mM DTT)
and incubated with shaking at 4‡C for 30 min. The nuclear extract
was then centrifuged for 15 min at 13 000Ug and supernatant was
aliquoted and stored at 380‡C. Protein concentration was determined
by the Bio-Rad protein assay kit.
2.3. Electrophoretic mobility shift assay (EMSA)
Double stranded oligonucleotides containing the NF-UB recogni-
tion sequence (5P-AGT TGA GGG GAC TTT CCC AGG-3P) were
end-labeled with [Q-32P]ATP. Nuclear extracts containing 5 Wg pro-
teins were incubated for 30 min with radiolabeled oligonucleotides
(2.5^5.0U104 cpm) in 20 Wl reaction bu¡er containing 2 Wg poly(dI-
dC), 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM
DTT, 1 Wg/ml bovine serum albumin, 10% (v/v) glycerol. Nuclear
protein-oligonucleotide complexes were resolved by electrophoresis
on a 6% non-denaturing polyacrylamide gel in 0.5U TBE bu¡er at
150 V for 2 h at 4‡C. The gel was dried and autoradiographed with
intensifying screen at 380‡C for 20 h. Subsequently, the relative
bands in nuclear fractions were quanti¢ed by densitometric scanning
of the X-ray ¢lms with a GS 700 Imaging Densitometer (Bio-Rad)
and a computer programme (Molecular Analyst, IBM).
2.4. Western blot analysis
Immunoblotting analysis of iNOS, IUB-K, p50 and p65 proteins was
performed on J774 cells incubated with LPS (10 Wg/ml) in the presence
or absence of PGE2 or iloprost at di¡erent time points. Cytosolic
fraction proteins were mixed with gel loading bu¡er (50 mM Tris/
10% SDS/10% glycerol/10% 2-mercaptoethanol/2 mg of bromophenol
per ml) in a ratio of 1:1, boiled for 3 min and centrifuged at 10 000Ug
for 10 min. Protein concentration was determined and equivalent
amounts (75 Wg) of each sample were electrophoresed in a 12% dis-
continuous polyacrylamide minigel. The proteins were transferred
onto nitrocellulose membranes, according to the manufacturer’s in-
structions (Bio-Rad). The membranes were saturated by incubation at
4‡C overnight with 10% non-fat dry milk in PBS and then incubated
with (1:1000) anti-iNOS, anti-IUB-K, anti-p50 and anti-p65 antibodies
for 1 h at room temperature. The membranes were washed three times
with 1% Triton 100-X in PBS and then incubated with anti-rabbit
immunoglobulins coupled to peroxidase (1:1000). The immunocom-
plexes were visualised by the ECL chemiluminescence method (Amer-
sham). Subsequently, the relative expression of iNOS, IUB-K, p50 and
p65 proteins in cytosolic and nuclear fractions was quanti¢ed by den-
sitometric scanning of the X-ray ¢lms with a GS 700 Imaging Densi-
tometer (Bio-Rad) and a computer programme (Molecular Analyst,
IBM).
2.5. Statistics
Results were expressed as the mean þ S.E.M. of n experiments.
Statistical analysis was determined by Student’s unpaired t-test with
P6 0.05 considered signi¢cant.
2.6. Reagents
LPS (from S. typhosa) was from Difco. Phosphate bu¡er saline was
from Celbio. DL-Dithiothreitol, phenylmethylsulfonyl£uoride, soybean
trypsin inhibitor, pepstatin A, leupeptin and benzamidine were from
Calbiochem. [Q-32P]ATP was from Amersham. Poly(dI-dC) was from
Boehringer. Anti-iNOS, anti-IUB-K, anti-p50, anti-p65 and anti-c-Rel
antibodies were from Santa Cruz. Non-fat dry milk was from Bio-
Rad. All the other reagents were from Sigma.
3. Results
3.1. E¡ect of PGs on LPS-induced nitrite production and iNOS
protein expression
The production of nitrite by unstimulated J774 macro-
phages was undetectable (6 1 nmol/106 cells; n = 3). The stim-
ulation of cells with LPS (10 Wg/ml) resulted in a time-depend-
ent accumulation of nitrite in the medium which reached
5.2 þ 0.5 nmol/106 cells at 6 h (n = 4), 18.1 þ 1.2 nmol/106 cells
at 12 h (n = 6), 45 þ 1.3 nmol/106 cells at 24 h (n = 8). More-
over, upon stimulation with LPS (10 Wg/ml) for 24 h, cells
expressed a signi¢cant high level of iNOS protein expression
when compared to control, untreated cells (Fig. 1). Pre-treat-
ment of cells with PGE2 (1, 10, 100 WM) and iloprost (0.1, 1,
10 WM) reduced in a concentration-dependent manner nitrite
accumulation at 24 h (by 15.1 þ 0.6%, 25.3 þ 1.1%, 43.2 þ 1.2%
and 13.0 þ 0.5%, 27.2 þ 1.3%, 46.7 þ 0.9%, respectively, n = 6).
The reduction of nitrite accumulation by prostanoids was
comparable to the inhibition of iNOS protein expression
(Fig. 1). In contrast, PGF2K (10 WM) and U46619 (a stable
analogue of thromboxane A2, 10 WM) did not a¡ect iNOS
protein expression and nitrite production (data not shown).
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Fig. 1. E¡ect of di¡erent concentrations of PGE2 and iloprost on
iNOS protein expression in J774 macrophages stimulated with LPS
(10 Wg/ml) for 24 h. Representative Western blot of iNOS protein
(A) as well as the densitometric analysis (B) shows the e¡ect of
PGE2 (0.1, 1, 10 WM) and iloprost (0.01, 0.1, 1 WM). Data are ex-
pressed as mean þ S.E.M. of three separate experiments. *P6 0.05;
**P6 0.01 vs. control (LPS alone).
Fig. 2. E¡ect of delayed addition of PGE2 and iloprost on iNOS
protein expression in J774 macrophages stimulated with LPS (10
Wg/ml) for 24 h. Representative Western blot of iNOS protein (A)
as well as the densitometric analysis (B) shows the e¡ect of PGE2
(10 WM) and iloprost (1 WM) added to the cells at the same time as
the LPS (time 0) or 12 h after LPS challenge on iNOS protein ex-
pression. Data are expressed as mean þ S.E.M. of three separate ex-
periments. **P6 0.01 vs. control (LPS alone at time 0).
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The addition of PGE2 (10 WM) and iloprost (1 WM) to the
cells 12 h after LPS challenge did not a¡ect either iNOS pro-
tein expression (Fig. 2) or nitrite accumulation at 24 h
(44.9 þ 1.6 nmol/106 cells, n = 4 and 41.2 þ 1.8 nmol/106 cells,
n = 4, respectively) indicating that both prostanoids did not
cause direct inhibition of iNOS activity.
3.2. E¡ect of PGs on NF-UB activation
The e¡ects of di¡erent concentrations of prostanoids on
NF-UB/DNA binding activity in J774 macrophages stimulated
for 2 h with LPS (10 Wg/ml) were tested by EMSA. A low
basal level of NF-UB/DNA binding activity was detected in
nuclear proteins from unstimulated macrophages. Conversely,
a retarded band was clearly detected following stimulation
with LPS (10 Wg/ml). Treatment of cells with PGE2 (1, 10,
100 WM) or iloprost (0.1, 1, 10 WM) caused a concentration-
dependent inhibition of NF-UB/DNA binding activity (Fig. 3).
The speci¢city of NF-UB/DNA binding complex was evident
by the complete displacement of NF-UB/DNA binding in the
presence of a 50-fold molar excess of unlabeled NF-UB probe
(W.T. 50U) in the competition reaction. In contrast a 50-fold
molar excess of unlabeled mutated NF-UB probe (Mut. 50U)
or SP-1 oligonucleotide (SP-1 50U) had no e¡ect on this
DNA-binding activity. The composition of the NF-UB com-
plex activated by LPS was determined using speci¢c antibod-
ies against p50 (p50), p65 (p65) and c-Rel (c-Rel) subunits of
NF-UB proteins. Addition of either anti-p50 or anti-p65 but
not c-Rel to the binding reaction resulted in a marked reduc-
tion of NF-UB band intensity (Fig. 4).
3.3. E¡ects of PGs on degradation of IUB-K and nuclear
translocation of NF-UB subunits
The e¡ects of prostanoid treatment on the presence of IUB-
K in the cytosolic fraction or p50 and p65 subunits in nuclear
fraction were examined by immunoblotting analysis. Unstim-
ulated cells expressed a basal level of either IUB-K in the
cytosolic fraction or p50 and p65 in the nuclear fraction.
When the cells were activated with LPS (10 Wg/ml), IUB-K
disappeared from the cytosolic fraction whereas p50 and
p65 level was increased in the nuclear fraction. Treatment of
cells with PGE2 (10 WM) and iloprost (1 WM) prevented either
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Fig. 5. E¡ect of PGE2 and iloprost on LPS-induced degradation of
IUB-K. Representative Western blot of IUB-K (A) as well as the den-
sitometric analysis (B) shows the e¡ect of PGE2 (10 WM) and ilo-
prost (1 WM) on degradation of IUB-K in J774 macrophages col-
lected 30 min after LPS (10 Wg/ml) challenge. Data are expressed as
mean þ S.E.M. of three separate experiments. ‡‡P6 0.01 vs. control
(unstimulated cells) ; **P6 0.01 vs. LPS-stimulated cells.
Fig. 3. E¡ect of di¡erent concentrations of PGE2 and iloprost on
NF-UB/DNA binding in J774 macrophages stimulated with LPS (10
Wg/ml) for 2 h. Representative EMSA of NF-UB (A) as well as the
densitometric analysis (B) shows the e¡ect of PGE2 (0.1, 1, 10 WM)
and iloprost (0.01, 0.1, 1 WM) on LPS-induced NF-UB/DNA binding
activity. Data are expressed as mean þ S.E.M. of three separate ex-
periments. *P6 0.05; **P6 0.01 vs. control (LPS alone).
Fig. 4. Identi¢cation of LPS-induced NF-UB/DNA binding proteins
in J774 macrophages. Nuclear extracts from LPS treated J774 mac-
rophages were prepared as described in Section 2 and incubated
with 32P-labelled NF-UB probe. In competition reaction nuclear ex-
tracts were incubated with radiolabeled NF-UB probe in the absence
or presence of identical but unlabeled oligonucleotides (W.T. 50U),
mutated non-functional UB probe (Mut. 50U) or unlabeled oligonu-
cleotide containing the consensus sequence for SP-1 (SP-1 50U). In
supershift experiments nuclear extracts were incubated with antibod-
ies against p50 (p50), p65 (p65) or c-Rel (c-Rel) 30 min before incu-
bation with radiolabeled NF-UB probe. Data illustrated are from a
single experiment and are representative of three separate experi-
ments.
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IUB-K degradation or p50 and p65 nuclear translocation
(Figs. 5 and 6, respectively).
4. Discussion
Prostaglandins modulate the immune and in£ammatory re-
sponse by controlling the production of some mediators such
as NO [19]. Previous studies demonstrated that PGE2 and
iloprost were able to inhibit the LPS-stimulated NO produc-
tion in J774 macrophages [4]. A similar role for PGs on the
NO pathway has been shown in murine peritoneal macro-
phages primed in vivo and activated in vitro with LPS [5].
The molecular mechanisms by which these prostanoids mod-
ulate iNOS expression are not yet known. The results of the
present study show that PGE2 or iloprost concentration-de-
pendently suppresses the LPS-induced iNOS protein expres-
sion in J774 macrophages. Inhibition by iloprost was more
e¡ective than that exhibited by PGE2. In fact, the LPS-in-
duced iNOS protein expression was abolished by 1 WM ilo-
prost compared to 10 WM PGE2. The inhibition of iNOS
protein expression by prostanoids was not dependent on di-
rect inhibition of iNOS activity since both compounds, when
added to the cells 12 h after LPS challenge, did not a¡ect the
enzyme catalytic activity suggesting the possibility that they
may act at transcriptional level. NF-UB activation has a key
role in the regulation of iNOS expression [12]. We investigated
the e¡ect of PGE2 and iloprost on LPS-induced NF-UB acti-
vation. Our data show that both prostanoids inhibited in a
concentration-related manner NF-UB/DNA binding activity.
In this respect, it is also interesting to note that iloprost was
more e¡ective than PGE2 in inhibiting NF-UB/DNA binding
activity. These results obtained with EMSA analysis were vir-
tually comparable to those observed with Western blotting.
PGE2 and iloprost also inhibited disappearance of IUB-K from
the cytosolic fraction and translocation of NF-UB subunits
into the nuclear fraction. The mechanisms by which PGE2
and iloprost block NF-UB activation may be related to an
inhibitory e¡ect on IUB-K degradation. Furthermore, the nu-
clear translocation of p50 and p65 subunits in LPS-stimulated
J774 macrophages was prevented by PGE2 and iloprost at the
same concentrations that blocked proteolytic degradation of
IUB-K, reinforcing the hypothesis that these compounds inhib-
it NF-UB activation by stabilising IUB-K. These results indi-
cate that PGE2 and iloprost inhibit NO synthase induction by
preventing NF-UB activation. Several in vitro studies have
de¢ned LPS and cytokine responsive elements on the iNOS
gene promoter and have identi¢ed NF-UB as the primary
transcription factor regulating iNOS expression after LPS or
cytokine challenge. The presence of NF-UB binding sequences
in the NO synthase promoter [7] and requirement of nuclear
translocation of NF-UB in NO synthase induction [12] were
supportive for the necessity of NF-UB activation in NO syn-
thase gene expression. Our results are consistent with this
hypothesis and suggest that the inhibition of NO synthase
induction by prostanoids occurs through the prevention of
NF-UB activation. The mechanism of action of prostaglandins
on the NO pathway has been attributed to increased intra-
cellular levels of the second messenger cAMP. A role of
cAMP as an intermediate in the down-regulation of iNOS
by PGE2 has been suggested in murine peritoneal macro-
phages primed in vivo [5] and in vitro in J774 macrophages
activated with LPS [20]. In addition, NO production by LPS-
stimulated J774 murine macrophages was inhibited by pro-
longed elevation of intracellular cAMP, suggesting that in
these cells cAMP may act as a mediator of the PGE2 inhib-
ition of iNOS induction [21]. A recent study showed that
cAMP elevating agents inhibited the functional activity of
endogenous NF-UB/Rel complexes in human monocytic and
endothelial cells [22]. The molecular mechanism by which
PGE2 and iloprost possibly inhibit iNOS expression could
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Fig. 6. E¡ect of PGE2 and iloprost on p50 and p65 nuclear translocation in J774 macrophages stimulated with LPS (10 Wg/ml) for 2 h. Repre-
sentative Western blot of p50 (A) and p65 (C) as well as the densitometric analysis (B and D, respectively) show the e¡ect of PGE2 (10 WM)
and iloprost (1 WM) on LPS-induced p50 and p65 nuclear translocation. Data are expressed as mean þ S.E.M. of three separate experiments.
*P6 0.05; **P6 0.01 vs. control (LPS alone).
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be related to their ability to increase intracellular cAMP levels
which in turn inhibit NF-UB/DNA binding activity. This view
is supported by the inability of PGF2K and U46619 (a stable
analogue of thromboxane A2) both of which do not a¡ect
cAMP to modulate iNOS expression. Five di¡erent classes
of prostanoid receptors have been described [23]. Amongst
these, EP2 and EP4 receptor subtypes (selective agonist
PGE2) and IP receptor (selective agonist iloprost) have been
shown to elevate the cAMP content in di¡erent cell lines
[24,25]. Although our work does not establish which of these
receptors are operative in J774 cells, our results showing that
iloprost is more e¡ective than PGE2 suggest a prevalent role
of IP receptors in mediating the above e¡ects. Nevertheless,
delineation of the mechanism(s) of negative transcriptional
regulation of iNOS promoter by cAMP remains to be shown.
In any case, the down-regulation of iNOS gene expression by
endogenous prostaglandins may represent a relevant feed-
back mechanism in modulating the sustained NO production
which occurs in many pathological events.
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